A citation-based method for searching scientific literature

Julia Landin, Walter P Weber. Breast Care (Basel) 2016
Times Cited: 2







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Joseph P Costantino, Takamaru Ashikaga, Donald L Weaver, Eleftherios P Mamounas, Lynne M Jalovec,[...]. Lancet Oncol 2010
978
100

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
845
100

Radiation field design in the ACOSOG Z0011 (Alliance) Trial.
Reshma Jagsi, Manjeet Chadha, Janaki Moni, Karla Ballman, Fran Laurie, Thomas A Buchholz, Armando Giuliano, Bruce G Haffty. J Clin Oncol 2014
214
100

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Jean-Francois Boileau, Brigitte Poirier, Mark Basik, Claire M B Holloway, Louis Gaboury, Lucas Sideris, Sarkis Meterissian, Angel Arnaout, Muriel Brackstone, David R McCready,[...]. J Clin Oncol 2015
374
100

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
709
100

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Abigail S Caudle, Wei T Yang, Savitri Krishnamurthy, Elizabeth A Mittendorf, Dalliah M Black, Michael Z Gilcrease, Isabelle Bedrosian, Brian P Hobbs, Sarah M DeSnyder, Rosa F Hwang,[...]. J Clin Oncol 2016
368
100

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
L M van Roozendaal, J H W de Wilt, T van Dalen, J A van der Hage, L J A Strobbe, L J Boersma, S C Linn, M B I Lobbes, P M P Poortmans, V C G Tjan-Heijnen,[...]. BMC Cancer 2015
39
100

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, Karla V Ballman, Peter D Beitsch, Pat W Whitworth, Peter W Blumencranz, A Marilyn Leitch, Sukamal Saha, Linda M McCall, Monica Morrow. JAMA 2011
100

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, Barbara Fleige, Maik Hausschild, Gisela Helms, Annette Lebeau, Cornelia Liedtke, Gunter von Minckwitz, Valentina Nekljudova,[...]. Lancet Oncol 2013
662
100

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
Philip M Poortmans, Sandra Collette, Carine Kirkove, Erik Van Limbergen, Volker Budach, Henk Struikmans, Laurence Collette, Alain Fourquet, Philippe Maingon, Mariacarla Valli,[...]. N Engl J Med 2015
624
100

Regional Nodal Irradiation in Early-Stage Breast Cancer.
Timothy J Whelan, Ivo A Olivotto, Wendy R Parulekar, Ida Ackerman, Boon H Chua, Abdenour Nabid, Katherine A Vallis, Julia R White, Pierre Rousseau, Andre Fortin,[...]. N Engl J Med 2015
692
100

[Sentinel node invasion: is it necessary to perform axillary lymph node dissection? Randomized trial SERC].
Gilles Houvenaeghel, Michel Resbeut, Jean-Marie Boher. Bull Cancer 2014
17
50

Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).
Bruce G Haffty, Linda M McCall, Karla V Ballman, Sarah McLaughlin, Reshma Jagsi, David W Ollila, Kelly K Hunt, Thomas A Buchholz, Judy C Boughey. Int J Radiat Oncol Biol Phys 2016
24
50

Assessment of morbidity from complete axillary dissection.
D Ivens, A L Hoe, T J Podd, C R Hamilton, I Taylor, G T Royle. Br J Cancer 1992
400
50



Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Priya Rastogi, Stewart J Anderson, Harry D Bear, Charles E Geyer, Morton S Kahlenberg, André Robidoux, Richard G Margolese, James L Hoehn, Victor G Vogel, Shaker R Dakhil,[...]. J Clin Oncol 2008
50

Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer.
Amit K Garg, Thomas A Buchholz. Ann Surg Oncol 2015
19
50

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.
Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt. BMC Cancer 2017
65
50

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Henry M Kuerer, Monet Bowling, Teresa S Flippo-Morton,[...]. JAMA 2013
717
50

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
Eleftherios P Mamounas, Stewart J Anderson, James J Dignam, Harry D Bear, Thomas B Julian, Charles E Geyer, Alphonse Taghian, D Lawrence Wickerham, Norman Wolmark. J Clin Oncol 2012
324
50

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Roman Rouzier, Jean-Marc Extra, Jerzy Klijanienko, Marie-Christine Falcou, Bernard Asselain, Anne Vincent-Salomon, Philippe Vielh, Edwige Bourstyn. J Clin Oncol 2002
239
50


Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Thomas A Buchholz, Constance D Lehman, Jay R Harris, Barbara A Pockaj, Nagi Khouri, Nola F Hylton, Michael J Miller, Timothy Whelan, Lori J Pierce, Laura J Esserman,[...]. J Clin Oncol 2008
142
50

The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.
Sarah Pesek, Taka Ashikaga, Lars Erik Krag, David Krag. World J Surg 2012
90
50


Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
Coen W Hurkmans, Jacques H Borger, Emiel J Th Rutgers, Geertjan van Tienhoven. Radiother Oncol 2003
49
50

Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.
P J Tanis, O E Nieweg, R A Valdés Olmos, B B Kroon. J Am Coll Surg 2001
178
50



De-escalation of axillary surgery in early breast cancer.
Ismail Jatoi, John R Benson, Masakazu Toi. Lancet Oncol 2016
41
50

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Eleftherios P Mamounas, Ann Brown, Stewart Anderson, Roy Smith, Thomas Julian, Barbara Miller, Harry D Bear, Christopher B Caldwell, Alonzo P Walker, Wendy M Mikkelson,[...]. J Clin Oncol 2005
334
50

Micrometastases or isolated tumor cells and the outcome of breast cancer.
Maaike de Boer, Carolien H M van Deurzen, Jos A A M van Dijck, George F Borm, Paul J van Diest, Eddy M M Adang, Johan W R Nortier, Emiel J T Rutgers, Caroline Seynaeve, Marian B E Menke-Pluymers,[...]. N Engl J Med 2009
351
50

Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000.
Montserrat Solá, José A Alberro, Manuel Fraile, Pilar Santesteban, Manuel Ramos, Rafael Fabregas, Antonio Moral, Blas Ballester, Sergi Vidal. Ann Surg Oncol 2013
157
50

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
M J Brady, D F Cella, F Mo, A E Bonomi, D S Tulsky, S R Lloyd, S Deasy, M Cobleigh, G Shiomoto. J Clin Oncol 1997
50

Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Michaella J Smith, P Grantley Gill, Neil Wetzig, Tatiana Sourjina, Val Gebski, Owen Ung, Ian Campbell, James Kollias, Xanthi Coskinas, Avis Macphee,[...]. Breast Cancer Res Treat 2009
14
50

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
Roberto Agresti, Gabriele Martelli, Marco Sandri, Elda Tagliabue, Maria Luisa Carcangiu, Ilaria Maugeri, Cristina Pellitteri, Cristina Ferraris, Giuseppe Capri, Angela Moliterni,[...]. Cancer 2014
48
50


ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.
Birgitte V Offersen, Liesbeth J Boersma, Carine Kirkove, Sandra Hol, Marianne C Aznar, Albert Biete Sola, Youlia M Kirova, Jean-Philippe Pignol, Vincent Remouchamps, Karolien Verhoeven,[...]. Radiother Oncol 2016
108
50

Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): reliability and validity.
Nele Devoogdt, Marijke Van Kampen, Inge Geraerts, Tina Coremans, Marie-Rose Christiaens. Phys Ther 2011
74
50

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
Judy C Boughey, Karla V Ballman, Huong T Le-Petross, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, Eric C Feliberti, Kelly K Hunt. Ann Surg 2016
225
50

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Robert E Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G Newcombe, J Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny,[...]. J Natl Cancer Inst 2006
50


Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique.
Mila Donker, Caroline A Drukker, Renato A Valdés Olmos, Emiel J Th Rutgers, Claudette E Loo, Gabe S Sonke, Jelle Wesseling, Tanja Alderliesten, Marie-Jeanne T F D Vrancken Peeters. Ann Surg Oncol 2013
41
50

DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.
Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Hella Danø, Martin Berg, Ingelise Jensen, Anders Navrsted Pedersen, Sune Jürg Zimmermann, Hans-Jürgen Brodersen, Marie Overgaard, Jens Overgaard. J Clin Oncol 2016
263
50

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.
Stephanie R Land, Jacek A Kopec, Thomas B Julian, Ann M Brown, Stewart J Anderson, David N Krag, Nicholas J Christian, Joseph P Costantino, Norman Wolmark, Patricia A Ganz. J Clin Oncol 2010
103
50

The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.
Rebecca J Tsai, Leslie K Dennis, Charles F Lynch, Linda G Snetselaar, Gideon K D Zamba, Carol Scott-Conner. Ann Surg Oncol 2009
217
50

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
C A Drukker, S G Elias, M V Nijenhuis, J Wesseling, H Bartelink, P Elkhuizen, B Fowble, P W Whitworth, R R Patel, F A de Snoo,[...]. Breast Cancer Res Treat 2014
35
50

Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
Christine Louis-Sylvestre, Krishna Clough, Bernard Asselain, Jacques René Vilcoq, Remy Jacques Salmon, François Campana, Alain Fourquet. J Clin Oncol 2004
150
50

Evaluation of skin dose associated with different frequencies of bolus applications in post-mastectomy three-dimensional conformal radiotherapy.
Fundagul Andic, Yasemin Ors, Rima Davutoglu, Sule Baz Cifci, Emine Burcin Ispir, Mehmet Ertugrul Erturk. J Exp Clin Cancer Res 2009
28
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.